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Introduction: Epstein-Barr virus-positive mucocutaneous ulcer is a newly recognized clinicopathologic entity in the
spectrum of Epstein-Barr virus-positive lymphoproliferative disorders. This entity is characterized by a self-limited,
indolent course.
Case presentation: We report the case of a 74-year-old, type 2 diabetic man who presented with an
ulceroinfiltrative skin lesion on the left side of his neck. Histological examination showed that the lesion consisted
of large atypical cells, some with Hodgkin-Reed-Sternberg-like morphology, in the midst of reactive lymphocytes,
plasma cells, eosinophils and histiocytes. The atypical cells were partially positive for CD45, CD20, CD79a, CD30,
B-cell lymphoma 2 and latent membrane protein 1 (CS.1-4), and negative for CD15, B-cell lymphoma 6 and CD10.
In situ hybridization for Epstein-Barr virus-encoded ribonucleic acid was positive. Two years before, the patient had
been diagnosed with a self-limited subcutaneous abscess in the same anatomic area that healed after antibiotic
therapy.
Conclusion: Older patients with positive Epstein-Barr virus serology may develop B-cell lymphoproliferations due to
age-related immune suppression. Epstein-Barr virus-encoded ribonucleic acid testing and clonality analysis,
eventually complemented with close clinical follow-up, should be performed for suspicious inflammatory lesions in
older patients.Introduction
Epstein-Barr virus (EBV)-positive mucocutaneous ulcer
is a newly recognized clinicopathologic entity in the
spectrum of EBV-positive lymphoproliferative disorders
(EBV-LPD) with a self-limited, indolent course [1]. It is
associated with various forms of immunosuppression, in-
cluding immunosenescence [1,2]. The localized nature of
the disease may be due to a minimal and transitory gap
in T-cell immunosurveillance [1-5].
By adulthood, more than 90% of individuals have be-
come infected with EBV due to oral transmission [1-14].
The viral envelope glycoprotein, gp350, has the capacity
to bind to the corresponding receptor on B lymphocytes,
the CD21 molecule. After insertion, the B cells become* Correspondence: fkurshumliu@yahoo.com
2Institute of Anatomic Pathology, University Clinical Center of Kosovo, “Rrethi
i Spitalit” p.n,10000, Prishtina, Republic of Kosova
Full list of author information is available at the end of the article
© 2012 Sadiku et al.; licensee BioMed Central
Commons Attribution License (http://creativec
reproduction in any medium, provided the orpersistently infected with the virus and may become
transformed and proliferate indefinitely if T cell immun-
ity is compromised [1-5]. It is well established that T
cells play a major role in controlling EBV-associated
oncogenesis [1-5]. This is complemented by the fact that
administration of immunosuppressive agents after trans-
plantation may lead to EBV-LPD [1-7].
Case presentation
A 74-year-old type 2 diabetic man presented with a
persistent ulceroinfiltrative skin lesion in the neck
(Figure 1A).
Two years before, the patient had had a self-limited sub-
cutaneous non-specific absceding inflammation in the
same site which healed after antibiotic therapy. Examin-
ation of a blood smear revealed slight hypochromic
anemia and unremarkable white blood cells and platelets.
The serum lactate dehydrogenase (LDH) was normal.Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 Gross appearance of the neck lesion at presentation (A) and after cyclophosphamide, doxorubicin, vincristine, prednisone,
and rituximab (CHOP + R) therapy (B).
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ultrasound of the abdomen were unremarkable.
Histopathology examination revealed the presence of
large atypical cells, some with Hodgkin-Reed-Sternberg
(HRS)-like morphology, in the midst of reactive lym-
phocytes, plasma cells, eosinophils and histiocytes
(Figures 2A-D).
The atypical cells were partially positive for CD45,
CD20, CD79a, CD30, B-cell lymphoma 2 (Bcl-2) and la-
tent membrane protein 1 (LMP1) (CS.1-4), while nega-
tive for CD15, B-cell lymphoma 6 (Bcl-6) and CD10.Figure 2 Microscopic features of the (A) polymorphic lymphoid infiltr
adnexal epidermal structures (×5; H&E stain) and (B) peripheral nerve
hemorrhage (×10; H&E stain). (D) In the midst of small reactive cells are lar
haematoxylin and eosin.The surrounding cells were CD3+/CD4+/CD8+/CD20+
reactive T and B cells associated with many CD68+ his-
tiocytes (Figures 3A-D). No immunoglobulin light
chain restriction could be demonstrated in paraffin-
embedded tissue immunohistochemistry. There were
confluent areas of “geographic” necrosis. The infiltrate
extended in between striated muscle and around per-
ipheral nerves.
The large atypical cells were positive for Epstein-
Barr virus-encoded RNA (EBER) in situ hybridization
(Figure 4A and B).ate extending between striated muscle cells and surrounding
s (×20; H&E stain). (C) There are confluent areas of necrosis and
ge atypical Reed-Sternberg-like tumor cells (×20; H&E stain). H & E,
Figure 3 Immunohistochemical analysis illustrates (A) negative reaction of the neoplastic cells for CD3 (×10; immunoperoxidase stain),
(B) positive reaction for CD20 (×10; immunoperoxidase stain), (C) positive reaction for CD30 (×10; immunoperoxidase stain) and (D)
Latent membrane protein 1 of Epstein-Barr virus (×20; immunoperoxidase stain).
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therapy regimen consisting of cyclophosphamide, doxo-
rubicin, vincristine, prednisone, and rituximab (CHOP +
R) that resulted in complete remission (Figure 1B).
He remains well after a follow-up period of two years.
Discussion
EBV-positive mucocutaneous ulcer (EBVMCU) is a re-
cently described EBV positive B-cell lymphoproliferation
that occurs in patients >50 years old due to iatrogenic or
age related immunosuppression [1,2,10,14]. This entity
takes part in the spectrum of EBV-associated lympho-
proliferative disorders together with reactive lymph nodeFigure 4 Epstein-Barr virus-encoded ribonucleic acid in situ hybridiza
atypical and Reed-Sternberg-like cells (×10 and x20; chromogenic inhyperplasia, polymorphic nodal lymphoproliferative dis-
ease and diffuse large B-cell lymphoma [1,2]. Two stud-
ies by Dojcinov et al. [1,2] characterize this lesion as a
shallow, sharply circumscribed mucosal or cutaneous
ulcer with a histological picture of large pleomorphic
blasts reminiscent of HRS cells associated with variable
numbers of reactive lymphocytes, plasma cells, histio-
cytes and eosinophils [1,2]. Besides histological features
described by the author, our case displays a deeper lesion
with prominent perineural invasion and infiltration be-
tween striated muscle. In spite of the deeper extension
of this lesion, the clinical presentation of our case is
more in line with EBVMCU than the EBV-positivetion illustrates (A and B) positive nuclear reaction of the large
situ hybridization stain).
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characterized by an aggressive clinical course [1,2,10,14].
As described in the literature, we, too, consider that the
border between reactive lesions and lymphoma can be im-
precise and classification between different types of age
related EBV lymphoproliferative disorder (AR-EBVLPD)
subtypes can be problematic [2].
EBV is causally related to a number of lymphoid neo-
plasms, such as Burkitt lymphoma, extranodal NK/T-cell
lymphoma nasal type, angioimmunoblastic T-cell lymph-
oma, some cases of classical Hodgkin’s lymphoma (cHL),
lymphomatoid granulomatosis, plasmablastic lymphoma,
primary effusion lymphoma and diffuse large B-cell
lymphoma associated with chronic inflammation [10,14].
On the other hand, there is a spectrum of lymphoproli-
ferative EBV-related lesions ranging from infectious
mononucleosis, a non-neoplastic self-limited infectious
syndrome to EBV-positive lymphoproliferative disease of
childhood, a potentially fatal lymphoproliferation [10,14].
Chronic active EBV infection is considered as an entity
that lies in between these two different prognostic cat-
egories, with a potential of evolving to a clonal and aggres-
sive lymphoproliferation [10].
Our case has many overlapping features with lympho-
matoid granulomatosis (LyG) and cHL. In more than
90% of cases, LyG presents with bilateral lung involve-
ment which was not the case in our patient [10,14]. The
presence of HRS-like cells in the background of inflam-
matory cells raises the possibility of cHL [10,14]. How-
ever, it is highly unusual for cHL to present at an
extranodal location [1,2,10,14]. Determination of immu-
nophenotype of the tumor cells is very helpful given that
HRS cells are usually positive both for CD30 and CD15
and may variably and heterogeneously express CD20
[10,14]. In the vast majority of cases of diffuse large B-
cell lymphoma (DLBCL) expressing CD30, the neoplas-
tic cells are CD15 negative [10,14].
Nonetheless, separation between DLBCL and cHL is be-
coming more and more difficult in some cases despite the
ever advancing diagnostic means. The emergence of the
entity designated as B-cell lymphoma unclassifiable, with
features intermediate between DLBCL and cHL is in line
with this conclusion [14]. Also, according to the emerging
literature, in EBV-LPD, including DLBCL, the tumor cells
express CD15 in concert with CD30 in a number of cases
[1,2,10,14]. It is well established that cHL is a neoplasm of
germinal center B-cell derivation due to the demonstra-
tion of weak Pax-5 expression by HRS cells by immuno-
histochemistry [10,14]. In retrospect, two years ago, our
patient had presented with a left-sided cervical mass that
in histology was revealed to be non-specific chronic
absceding inflammation. Until the current clinical presen-
tation the patient had had an uneventful clinical history,
besides the underlying diabetes.Conclusions
The fact that the current lesion was located in the same
anatomical area as the previously diagnosed abscess
raises the theoretical possibility of a stepwise process
that gradually evolved from a reactive process to oligo-
clonal and clonal neoplastic proliferation. Another hy-
pothesis is the possibility of the first lesion to be an
overlooked EBV-LPD that underwent spontaneous re-
gression, given that EBER in situ hybridization and
clonality analysis were not performed.
“Non-specific” inflammatory lesions of unusual loca-
tions in older patients should be viewed with caution
due to the possibility of synchronous or metachronous
neoplasia. When in the slightest doubt, EBER testing
and clonality analysis should be performed, eventually
complemented with close clinical follow-up.
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